COMMUNIQUÉS West-GlobeNewswire

Vaxil Bio Enters Into Definitive Agreement With Green Data Centers for Reverse Take Over
21/08/2024
Not for distribution to United States newswire services or for release, publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. Any failure to comply with [...]
Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium
21/08/2024
HealthCCSng V2.0 i ntroduces additional ‘ zero calcium ’ categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding CAC d etection c ategory output Marks second FDA 510(k [...]
Centessa Pharmaceuticals to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
21/08/2024
BOSTON and LONDON, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today [...]
Aging in Place, Lack of Transportation and Access, and Economic Insecurity Are Top Three Social Barriers to U.S. Senior Health
21/08/2024
Alignment Health’s 2024 Social Threats to Aging Well in America survey reveals 1 in 4 seniors skip medical care, 1 in 5 seniors do not have enough money to pay off medical debt in next year ORANGE, Calif. , Aug. 21, [...]
ANY LAB TEST NOW AND ARCPOINT CREATE LARGEST FRANCHISE DIRECT ACCESS LAB TESTING GROUP IN THE UNITED STATES
20/08/2024
Greenville, South Carolina, Aug. 20, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) is pleased to announce that it has entered into a transaction, dated August 20, 2024, with Any [...]
Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting
20/08/2024
REDWOOD CITY, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will participate in a presentation and panel discussion at the [...]
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
20/08/2024
MENLO PARK, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, [...]
OrthoPediatrics Corp. to Host Investor Day on September 12, 2024
20/08/2024
WARSAW, Ind., Aug. 20, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]
Windtree Therapeutics Reports Second Quarter 2024 Financial Results and Provides Key Business Updates
20/08/2024
WARRINGTON, Pa., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for [...]
Tectonic Therapeutic to Participate in September Investor Conferences
20/08/2024
WATERTOWN, Mass., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (Tectonic), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and [...]
Galapagos receives transparency notification from FMR LLC
20/08/2024
Mechelen, Belgium; 20 August 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from FMR LLC. Pursuant to Belgian transparency legislation 1 , [...]
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
20/08/2024
Bagsværd, Denmark, 20 August 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance [...]
KFSHRC Showcases Medical Education Innovations at AMEE 2024 Switzerland
20/08/2024
RIYADH, Saudi Arabia, Aug. 20, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is further expanding its global footprint by participating in the 2024 International Association for [...]
Emergent BioSolutions Finalizes Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals
20/08/2024
GAITHERSBURG, Md., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has completed the sale of its drug product facility in Baltimore-Camden to an affiliate of Bora [...]
Gynesonics® Reaches Milestone with 10,000th Patient Treatment with Sonata System
20/08/2024
Cutting-edge incision-free solution advances standard of care for women with uterine fibroids REDWOOD CITY, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Gynesonics ® , Inc. a privately-held women’s healthcare medical [...]
U.S. Oral Surgery Management Recognized by Dallas Business Journal as one of the Region’s Fastest Growing Companies
20/08/2024
IRVING, Texas, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The Dallas Business Journal has named Irving’s U.S. Oral Surgery Management ( USOSM ) to this year’s Fast 50 – a list of the 50 fastest growing companies in the Dallas- [...]
PanOmiQ Set’s New Benchmark with 100% Accuracy in Whole Genome Sequencing Testing
20/08/2024
BioAro’s Cutting-Edge AI-Powered Software is now available for a 15-day free trial CALGARY, Alberta, Aug. 20, 2024 (GLOBE NEWSWIRE) -- BioAro, a leading precision health and genomics company, is proud to announce a [...]
SPARK NS Awards Five Projects Up to $10 Million to Advance Academic Discoveries in Parkinson’s Disease from the Lab to the Clinic
20/08/2024
Academic research teams participate in a two-year translational research program that eliminates barriers that prevent promising discoveries from benefitting patients MENLO PARK, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE [...]
FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology
20/08/2024
HOUSTON, Aug. 20, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of [...]

Pages